BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36354691)

  • 1. Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
    Kosmala A; Serfling SE; Schlötelburg W; Lindner T; Michalski K; Schirbel A; Higuchi T; Hartrampf PE; Buck AK; Weich A; Werner RA
    Clin Nucl Med; 2023 Jan; 48(1):35-42. PubMed ID: 36354691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of early and late
    Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
    Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Koerber SA; Röhrich M; Walkenbach L; Liermann J; Choyke PL; Fink C; Schroeter C; Spektor AM; Herfarth K; Walle T; Calais J; Kauczor HU; Jaeger D; Debus J; Haberkorn U; Giesel FL
    J Nucl Med; 2023 Nov; 64(11):1712-1720. PubMed ID: 37678928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors.
    Weich A; Serfling SE; Schlötelburg W; Higuchi T; Hartrampf PE; Schirbel A; Heinrich M; Buck AK; Rowe SP; Kosmala A; Werner RA
    Clin Nucl Med; 2023 Jul; 48(7):586-593. PubMed ID: 37167408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Huang D; Wu J; Zhong H; Li Y; Han Y; He Y; Chen Y; Lin S; Pang H
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):908-920. PubMed ID: 36326867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior Tumor Detection for
    Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
    J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
    Rajaraman V; Meenakshi LA; Selvaraj AJ; Pottakkat B; Halanaik D
    Clin Nucl Med; 2023 Jun; 48(6):e281-e288. PubMed ID: 37019124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Guberina N; Kessler L; Pöttgen C; Guberina M; Metzenmacher M; Herrmann K; Mucha M; Rischpler C; Indenkämpen F; Siveke JT; Treckmann J; Umutlu L; Kasper S; Fendler WP; Stuschke M
    Sci Rep; 2022 Sep; 12(1):16261. PubMed ID: 36171444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Röhrich M; Syed M; Liew DP; Giesel FL; Liermann J; Choyke PL; Wefers AK; Ritz T; Szymbara M; Schillings L; Heger U; Rathke H; Kratochwil C; Huber PE; von Deimling A; Debus J; Kauczor HU; Haberkorn U; Adeberg S
    Radiother Oncol; 2021 Jul; 160():192-201. PubMed ID: 33940087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.